Hydrocodone Bitartrate And Acetaminophen Tablet
Product Images NDC 71335-1557

3 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydrocodone Bitartrate And Acetaminophen (NDC 71335-1557). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Hydrocodone 01)

Chemical Structure (Hydrocodone 01)
Chemical structure diagram depicting the active ingredients Hydrocodone Bitartrate and Acetaminophen. The left structure shows the complex ringed structure of Hydrocodone, while the right structure shows the bitartrate component with associated hydrate.*
FDA Label Image

Chemical Structure (Hydrocodone 02)

Chemical Structure (Hydrocodone 02)
Chemical structure of Hydrocodone Bitartrate and Acetaminophen active ingredient showing the molecular arrangement with a benzene ring bonded to an OH group and an acetamide group (CH3CONH).*
FDA Label Image

Label Image (Lbl713351557)

Label Image (Lbl713351557)
Label for Hydrocodone Bitartrate and Acetaminophen 7.5 mg / 325 mg tablets, a Schedule II controlled substance (CII), packaged by Bryant Ranch Prepack. The label notes comparison to Norco 7.5/325 mg tablets by Halo Pharmaceuticals Inc., includes storage instructions at 20°-25°C (68°-77°F), a caution for overdose and addiction risks, and a barcode with NDC 71335-1557-71. The label also advises keeping the drug out of reach of children and is marked Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.